BRD-8000.3

BRD-8000.3, as a specific EfpA inhibitor, is a narrow-spectrum, bactericidal antimycobacterial agent with good wild-type activity. BRD-8000.3 can be used for the research of tuberculosis[1].

Product Specifications

CAS Number

[2365504-95-4]

UNSPSC

12352005

Target

Antibiotic

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/brd-8000-3.html

Concentration

10mM

Purity

99.65

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

O=C([C@@H]1C(C)(C)[C@H]1/C=C(C)\C)NC2=NC(Br)=C(C3=NC=CC=N3)C=C2

Molecular Formula

C19H21BrN4O

Molecular Weight

401.30

References & Citations

[1]Johnson EO, et al. Large-Scale Chemical-Genetic Strategy Enables the Design of Antimicrobial Combination Chemotherapy in Mycobacteria. ACS Infect Dis. 2020;6 (1) :56-63.